| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mercury ion binding | 2.90e-05 | 8 | 163 | 3 | GO:0045340 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 3.36e-05 | 23 | 163 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 5.56e-05 | 26 | 163 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 1.99e-04 | 146 | 163 | 7 | GO:0016810 | |
| GeneOntologyMolecularFunction | fibronectin binding | 2.54e-04 | 38 | 163 | 4 | GO:0001968 | |
| GeneOntologyMolecularFunction | calcium ion binding | DSG1 ASAH2 SPTAN1 FKBP9 ITLN2 MYOF CDH20 USP32 FKBP7 PLCB2 MMP13 PADI2 PCDH1 PCDH18 CDH11 ASAH2B | 4.30e-04 | 749 | 163 | 16 | GO:0005509 |
| GeneOntologyBiologicalProcess | regulation of dopamine metabolic process | 2.82e-05 | 23 | 161 | 4 | GO:0042053 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | RELN PARK7 L1CAM CPEB3 CHRNA5 CHRNA7 SLC6A3 MET MYOF OSBPL2 SLC12A4 SYNJ1 P2RX2 KDR KIF5A BSN SLC12A7 IGSF21 CDH11 CA7 | 3.99e-05 | 931 | 161 | 20 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | RELN PARK7 L1CAM CPEB3 CHRNA5 CHRNA7 SLC6A3 MET MYOF OSBPL2 SLC12A4 SYNJ1 P2RX2 KDR KIF5A BSN SLC12A7 IGSF21 CDH11 CA7 | 3.99e-05 | 931 | 161 | 20 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | RELN PARK7 L1CAM CPEB3 CHRNA5 CHRNA7 SLC6A3 MET MYOF OSBPL2 SLC12A4 SYNJ1 P2RX2 KDR KIF5A BSN SLC12A7 IGSF21 CDH11 CA7 | 4.50e-05 | 939 | 161 | 20 | GO:0099537 |
| GeneOntologyBiologicalProcess | regulation of catecholamine metabolic process | 4.68e-05 | 26 | 161 | 4 | GO:0042069 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 5.77e-05 | 53 | 161 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell junction organization | CACNA1S RELN SDK2 DSG1 DSP TNC L1CAM CPEB3 CSMD2 ITGAM ITGB3 CHRNA7 NEDD9 ARHGAP6 CDH20 P2RX2 KDR BSN IGSF21 CDH11 | 7.45e-05 | 974 | 161 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | synaptic signaling | RELN PARK7 L1CAM CPEB3 CHRNA5 CHRNA7 SLC6A3 MET MYOF OSBPL2 SLC12A4 SYNJ1 P2RX2 KDR KIF5A BSN SLC12A7 IGSF21 CDH11 CA7 | 7.67e-05 | 976 | 161 | 20 | GO:0099536 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.13e-04 | 187 | 161 | 8 | GO:0007156 | |
| GeneOntologyCellularComponent | plasma membrane raft | 1.70e-04 | 147 | 165 | 7 | GO:0044853 | |
| GeneOntologyCellularComponent | synaptic membrane | L1CAM CSMD2 ITGB3 CHRNA5 CHRNA7 SLC6A3 SLC6A8 MET SLC16A3 SYNJ1 P2RX2 BSN AKAP1 IGSF21 | 2.24e-04 | 583 | 165 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | anchoring junction | FLNC DSG1 DSP TNC RPS3A PARK7 SPTAN1 L1CAM ZNF185 ITGB3 PGM5 NEDD9 CDH20 MDC1 KDR MMP13 IGSF21 PCDH1 CDH11 | 2.63e-04 | 976 | 165 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | postsynapse | CACNA1S DPYSL2 RPS3A SPTAN1 CPEB3 CSMD2 ITGB3 HNRNPD CHRNA5 CHRNA7 SLC6A3 SLC6A8 MET SLC16A3 P2RX2 KIF5A BSN AKAP1 IGSF21 | 4.43e-04 | 1018 | 165 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | membrane raft | ASAH2 PARK7 ITLN2 ITGAM CHRNA7 SLC6A3 MYOF SCARB1 KDR ASAH2B | 6.24e-04 | 362 | 165 | 10 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | ASAH2 PARK7 ITLN2 ITGAM CHRNA7 SLC6A3 MYOF SCARB1 KDR ASAH2B | 6.51e-04 | 364 | 165 | 10 | GO:0098857 |
| GeneOntologyCellularComponent | cholinergic synapse | 6.66e-04 | 22 | 165 | 3 | GO:0098981 | |
| MousePheno | decreased embryonic cilium number | 1.84e-05 | 6 | 138 | 3 | MP:0013197 | |
| Domain | Ceramidse_alk_C | 7.48e-05 | 2 | 162 | 2 | PF17048 | |
| Domain | NEUT/ALK_ceramidase_C | 7.48e-05 | 2 | 162 | 2 | IPR031331 | |
| Domain | Ceramidase_alk | 7.48e-05 | 2 | 162 | 2 | IPR006823 | |
| Domain | B9_dom | 2.23e-04 | 3 | 162 | 2 | IPR010796 | |
| Domain | B9 | 2.23e-04 | 3 | 162 | 2 | PS51381 | |
| Domain | B9-C2 | 2.23e-04 | 3 | 162 | 2 | PF07162 | |
| Pubmed | DPYSL2 ACACA DSP NOA1 PARK7 SPTAN1 HSPH1 L1CAM CYP51A1 FKBP9 PAICS TXNDC12 BUD23 MET MYOF TUBB4B PRRC2C HPRT1 SCARB1 MDC1 NUP210 TMX3 POGLUT2 AKAP1 G6PD CRTAP | 5.53e-10 | 1297 | 165 | 26 | 33545068 | |
| Pubmed | EPRS1 FLNC RAP1GAP ACACA DSG1 DSP TNC MTHFD2 RPS3A SPTAN1 HSPH1 ZNF185 TUBB4B PRRC2C GCN1 ALPG | 1.77e-09 | 488 | 165 | 16 | 31324722 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 FLNC DPYSL2 ACACA DSG1 DSP RPS3A PARK7 SPTAN1 HSPH1 ZNF185 PFKL PAICS HNRNPD NUP205 BUD23 TUBB4B UPF2 MDC1 SMARCA1 AATF GCN1 MVP G6PD PCK2 | 6.32e-09 | 1353 | 165 | 25 | 29467282 |
| Pubmed | EPRS1 FLNC DPYSL2 DSG1 DSP RPS3A NUP205 MYOF TUBB4B GCN1 MVP G6PD | 3.66e-08 | 312 | 165 | 12 | 37120454 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DPYSL2 FRAS1 HSPH1 L1CAM CYP51A1 FKBP9 PAICS CHRNA5 TXNDC12 SLC6A8 MET MYOF CSGALNACT2 SLC16A3 SCARB1 NUP210 FKBP7 TMX3 POGLUT2 AKAP1 G6PD CRTAP | 6.54e-08 | 1201 | 165 | 22 | 35696571 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNC FRAS1 ACACA MFHAS1 FOSL2 MEX3D L1CAM CEP192 REXO1 ADCY7 SLC6A8 MYOF KMT2D SLC12A4 SYNJ1 ZNRF3 SCARB1 PCYT2 ARRDC2 GCN1 MED13 | 7.25e-08 | 1105 | 165 | 21 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 ACACA DNAH10 DSG1 DSP RPS3A PARK7 SPTAN1 RGS22 HSPH1 PFKL OLA1 PAICS HNRNPD NUP205 CLPB HPRT1 MDC1 NUP210 SMARCA1 MTR BSN GCN1 G6PD | 7.47e-08 | 1425 | 165 | 24 | 30948266 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 FLNC ACACA DSG1 DSP RPS3A SPTAN1 PAICS HNRNPD TUBB4B CILP2 NUP210 GCN1 PCK2 | 7.55e-08 | 477 | 165 | 14 | 31300519 |
| Pubmed | EPRS1 FLNC DPYSL2 RAP1GAP DSP TNC RPS3A PARK7 SPTAN1 HSPH1 L1CAM ZNF185 FKBP9 PFKL OLA1 HNRNPD TUBB4B AGO1 CLCN6 UPF2 SYNJ1 PRRC2C BSN PCDH1 | 8.08e-08 | 1431 | 165 | 24 | 37142655 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CACNA1F EPRS1 CRISP2 DPYSL2 ACACA DSP HSPH1 DNAH2 PFKL CSMD2 NUP205 TUBB4B CDH20 DENND4B CCDC87 PHF14 NCR1 | 9.27e-08 | 736 | 165 | 17 | 29676528 |
| Pubmed | DPYSL2 DSP RPS3A PARK7 SPTAN1 HSPH1 PFKL OLA1 ITGB3 PAICS TUBB4B HPRT1 SCARB1 CD101 MVP | 9.36e-08 | 565 | 165 | 15 | 20458337 | |
| Pubmed | FLNC DPYSL2 DSP MFHAS1 SPTAN1 HSPH1 CYP51A1 PAICS OSBPL2 SLC12A4 PRRC2C SCARB1 SLC12A7 AKAP1 GCN1 | 1.00e-07 | 568 | 165 | 15 | 37774976 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNC DPYSL2 SPTAN1 HSPH1 PFKL ITGAM ITGB3 MYOF TUBB4B HPRT1 GCN1 G6PD | 1.06e-07 | 344 | 165 | 12 | 30333137 |
| Pubmed | EPRS1 FLNC DPYSL2 RELN SPTAN1 ITGB3 PAICS MET TUBB4B PRRC2C MVP G6PD | 1.72e-07 | 360 | 165 | 12 | 33111431 | |
| Pubmed | 3.37e-07 | 248 | 165 | 10 | 32963011 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 FLNC ACACA DSP PARK7 SPTAN1 HSPH1 OLA1 PAICS HNRNPD TXNRD1 MYOF TUBB4B HPRT1 ELAPOR1 GCN1 G6PD | 3.38e-07 | 807 | 165 | 17 | 30575818 |
| Pubmed | EPRS1 FLNC INTU DSP SPTAN1 HSPH1 DNAH2 NEB ADCY6 HNRNPD NUP205 CLCN4 SLC12A4 PRRC2C SMARCA1 CFAP74 PHF14 AATF KDR KIF5A OR10G8 BSN MED13 | 3.73e-07 | 1442 | 165 | 23 | 35575683 | |
| Pubmed | 3.76e-07 | 192 | 165 | 9 | 20602615 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 CACNA1S FLNC DPYSL2 ACACA RPS3A SPTAN1 HSPH1 FKBP9 PFKL OLA1 PAICS HNRNPD NUP205 TXNRD1 TUBB4B HPRT1 MTR PCYT2 GCN1 MVP G6PD CRTAP | 4.36e-07 | 1455 | 165 | 23 | 22863883 |
| Pubmed | EPRS1 DPYSL2 PDE6C PDE6B RPS3A PARK7 SPTAN1 PFKL PAICS HNRNPD TUBB4B SYNJ1 HPRT1 G6PD | 4.41e-07 | 552 | 165 | 14 | 36293380 | |
| Pubmed | EPRS1 DSG1 DSP RPS3A PARK7 SPTAN1 PAICS HNRNPD NUP205 TUBB4B CSF2RB PRRC2C HPRT1 GCN1 G6PD | 4.66e-07 | 641 | 165 | 15 | 36057605 | |
| Pubmed | EPRS1 FLNC DPYSL2 DSG1 DSP RPS3A SPTAN1 PAICS HNRNPD MYOF TUBB4B GCN1 | 4.88e-07 | 397 | 165 | 12 | 21319273 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | EPRS1 FLNC DPYSL2 DSG1 DSP RPS3A SPTAN1 HSPH1 TXNDC12 MKS1 NUP205 TUBB4B B9D1 GCN1 | 5.70e-07 | 564 | 165 | 14 | 21565611 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNC DPYSL2 ACACA DSG1 DSP MTHFD2 HSPH1 CYP51A1 ZNF185 PFKL OLA1 ITGAM PAICS HNRNPD NUP205 TXNRD1 MYOF TUBB4B AATF GCN1 MVP G6PD | 5.92e-07 | 1367 | 165 | 22 | 32687490 |
| Pubmed | FLNC DPYSL2 DSG1 DSP RPS3A PARK7 HSPH1 NEB PAICS HNRNPD TUBB4B AGO1 CLPB HPRT1 GCN1 MVP G6PD | 6.27e-07 | 844 | 165 | 17 | 25963833 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 ACACA DSG1 DSP RPS3A PARK7 SPTAN1 HSPH1 PRSS56 PFKL OLA1 PAICS HNRNPD TXNDC12 TXNRD1 TUBB4B SLC16A3 PRRC2C HPRT1 MDC1 GCN1 G6PD | 1.05e-06 | 1415 | 165 | 22 | 28515276 |
| Pubmed | 1.26e-06 | 164 | 165 | 8 | 32409323 | ||
| Pubmed | 1.39e-06 | 290 | 165 | 10 | 32929329 | ||
| Pubmed | 1.41e-06 | 225 | 165 | 9 | 31478661 | ||
| Pubmed | EPRS1 DPYSL2 DSG1 DSP RPS3A PARK7 HSPH1 PFKL OLA1 HNRNPD MYOF TUBB4B SMARCA1 GCN1 MVP G6PD | 1.57e-06 | 803 | 165 | 16 | 36517590 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNC DPYSL2 ACACA DSG1 SPTAN1 HSPH1 PFKL OLA1 HNRNPD MYOF AGO1 UPF2 PRRC2C AATF GCN1 | 2.10e-06 | 724 | 165 | 15 | 36232890 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 DSG1 DSP RPS3A SPTAN1 HSPH1 ZNF185 PFKL PAICS HNRNPD NUP205 MYOF TUBB4B UPF2 PRRC2C MDC1 NUP210 SMARCA1 AATF MVP | 2.39e-06 | 1257 | 165 | 20 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EPRS1 ACACA DSG1 DSP MTHFD2 RPS3A PARK7 HSPH1 CYP51A1 PFKL PAICS HNRNPD NUP205 TUBB4B CLPB HPRT1 NUP210 MTR TMX3 GCN1 | 2.39e-06 | 1257 | 165 | 20 | 37317656 |
| Pubmed | DSP RPS3A PARK7 SPTAN1 HSPH1 HNRNPD NUP205 TUBB4B HPRT1 MDC1 NUP210 GCN1 | 2.42e-06 | 463 | 165 | 12 | 34901782 | |
| Pubmed | 3.09e-06 | 317 | 165 | 10 | 30997501 | ||
| Pubmed | FLNC DPYSL2 ACACA DSP RPS3A SPTAN1 PAICS NUP205 PRRC2C MDC1 NUP210 AATF GCN1 MVP | 3.15e-06 | 653 | 165 | 14 | 22586326 | |
| Pubmed | EPRS1 CYP51A1 PFKL OLA1 PAICS NUP205 BTN3A3 CSGALNACT2 PIK3CG PRRC2C NUP210 KIF5A PLD1 AKAP1 GCN1 MVP MUL1 G6PD MED13 | 3.17e-06 | 1168 | 165 | 19 | 19946888 | |
| Pubmed | EPRS1 ACACA DSG1 DSP MTHFD2 RPS3A PARK7 PFKL HNRNPD TUBB4B PRRC2C MAPK7 GCN1 G6PD | 3.27e-06 | 655 | 165 | 14 | 35819319 | |
| Pubmed | ACACA DSP SPTAN1 DNAH2 HNRNPD NUP205 MYOF TUBB4B SLC12A4 CLPB SLC16A3 MDC1 NUP210 AKAP1 G6PD | 3.44e-06 | 754 | 165 | 15 | 35906200 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 24747678 | ||
| Pubmed | EPRS1 MTHFD2 PARK7 SPTAN1 CYP51A1 FKBP9 PAICS HNRNPD TXNDC12 TXNRD1 MSRB2 MYOF SCARB1 TMX3 PCK2 CRTAP | 3.71e-06 | 859 | 165 | 16 | 31536960 | |
| Pubmed | DPYSL2 RPS3A PARK7 HSPH1 OLA1 HNRNPD TXNRD1 TUBB4B HPRT1 G6PD | 4.29e-06 | 329 | 165 | 10 | 35562734 | |
| Pubmed | 4.40e-06 | 330 | 165 | 10 | 32529326 | ||
| Pubmed | EPRS1 FLNC DSP RPS3A SPTAN1 HSPH1 PFKL PAICS HNRNPD TUBB4B GCN1 MVP | 4.69e-06 | 494 | 165 | 12 | 26831064 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FNBP1 EPRS1 ACACA DSP FOSL2 SPTAN1 REXO1 ADCY6 HNRNPD MYOF KMT2D MDC1 PHF14 AKAP1 MED13 | 4.72e-06 | 774 | 165 | 15 | 15302935 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNC ACACA DSG1 DSP RPS3A HSPH1 PRSS56 CYP51A1 PAICS HNRNPD TXNDC12 NUP205 BUD23 TUBB4B MDC1 PHF14 AATF | 5.27e-06 | 989 | 165 | 17 | 36424410 |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | FNBP1 EPRS1 DSP RPS3A PARK7 HSPH1 PAICS HNRNPD NUP205 TUBB4B HPRT1 | 5.58e-06 | 418 | 165 | 11 | 32552912 |
| Pubmed | Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | 5.64e-06 | 93 | 165 | 6 | 38245532 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.93e-06 | 202 | 165 | 8 | 33005030 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | EPRS1 HSPH1 L1CAM PAICS MYOF TUBB4B NUP210 GCN1 MVP G6PD PCK2 | 6.10e-06 | 422 | 165 | 11 | 27342126 |
| Pubmed | 6.49e-06 | 55 | 165 | 5 | 33067418 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ACACA RPS3A PARK7 HNRNPD NUP205 BUD23 TUBB4B UPF2 HPRT1 SMARCA1 PCYT2 TBC1D23 GCN1 PCK2 | 7.42e-06 | 704 | 165 | 14 | 29955894 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 8.61e-06 | 281 | 165 | 9 | 30455355 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 8.75e-06 | 357 | 165 | 10 | 37059091 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 FLNC DPYSL2 ACACA DSP RPS3A PARK7 SPTAN1 HSPH1 PFKL PAICS HNRNPD TXNDC12 TUBB4B PRRC2C HPRT1 GCN1 G6PD | 9.75e-06 | 1149 | 165 | 18 | 35446349 |
| Pubmed | 1.02e-05 | 156 | 165 | 7 | 32850835 | ||
| Pubmed | EPRS1 FLNC MTHFD2 RPS3A HSPH1 PAICS HNRNPD TUBB4B PRRC2C HPRT1 NUP210 SMARCA1 MTR GCN1 | 1.03e-05 | 725 | 165 | 14 | 27025967 | |
| Pubmed | EPRS1 DPYSL2 RELN RAP1GAP DSP SPTAN1 HSPH1 PAICS TUBB4B CLPB SYNJ1 RALBP1 USP32 KIF5A TBC1D23 PADI2 MVP MED13 CRTAP | 1.22e-05 | 1285 | 165 | 19 | 35914814 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 16615126 | ||
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.26e-05 | 224 | 165 | 8 | 28443643 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 DSG1 DSP MTHFD2 RPS3A SPTAN1 HSPH1 PFKL HNRNPD BUD23 NEDD9 TUBB4B SLC16A3 MDC1 AATF MVP | 1.28e-05 | 949 | 165 | 16 | 36574265 |
| Pubmed | EPRS1 FLNC DSG1 DSP RPS3A SPTAN1 HSPH1 PAICS HNRNPD TUBB4B PRRC2C HPRT1 | 1.40e-05 | 551 | 165 | 12 | 34728620 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | EPRS1 FLNC DSG1 DSP RPS3A SPTAN1 HSPH1 HNRNPD TUBB4B PRRC2C CCDC87 MVP | 1.58e-05 | 558 | 165 | 12 | 27591049 |
| Pubmed | EPRS1 MTHFD2 RPS3A SPTAN1 HSPH1 HNRNPD NUP205 TUBB4B HPRT1 GCN1 | 1.61e-05 | 383 | 165 | 10 | 29331416 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TNC CYP51A1 PFKL PAICS ZNRF3 RALBP1 HPRT1 PCYT2 AATF KIF5A MAPK7 MVP | 1.64e-05 | 560 | 165 | 12 | 21653829 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PARK7 SPTAN1 ZNF185 OLA1 PAICS TUBB4B SLC16A3 SYNJ1 CASKIN2 SCARB1 GCN1 PCDH1 | 1.79e-05 | 565 | 165 | 12 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SHISA2 ADCY6 SLC6A8 MET SLC12A4 SLC16A3 CASKIN2 SCARB1 USP32 SLC12A7 PCDH1 PCDH18 | 1.92e-05 | 569 | 165 | 12 | 30639242 |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | EPRS1 L1CAM PRSS56 CYP51A1 MYOF SLC16A3 SCARB1 PLD1 GCN1 PCK2 | 1.96e-05 | 392 | 165 | 10 | 33144569 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | EPRS1 HSPH1 CYP51A1 OLA1 PAICS NUP205 TUBB4B OSBPL2 CLPB HPRT1 MTR GCN1 | 1.98e-05 | 571 | 165 | 12 | 37167062 |
| Pubmed | Genomic structure and promoter analysis of the mouse neutral ceramidase gene. | 2.24e-05 | 2 | 165 | 2 | 12435403 | |
| Pubmed | PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. | 2.24e-05 | 2 | 165 | 2 | 17173040 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26085644 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30719715 | ||
| Pubmed | Same origins of DNA replication function on the active and inactive human X chromosomes. | 2.24e-05 | 2 | 165 | 2 | 12616531 | |
| Pubmed | Nicotinic acetylcholine receptor alpha 7 regulates cAMP signal within lipid rafts. | 2.24e-05 | 2 | 165 | 2 | 12748066 | |
| Pubmed | A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. | 2.24e-05 | 2 | 165 | 2 | 17334805 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31306055 | ||
| Pubmed | The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab. | 2.24e-05 | 2 | 165 | 2 | 33727583 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 35599981 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10753931 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29736031 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31477752 | ||
| Pubmed | Attenuated expression of tenascin-C in ovalbumin-challenged STAT4-/- mice. | 2.24e-05 | 2 | 165 | 2 | 21205293 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30038560 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25485098 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 35354041 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31520365 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24659784 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26305376 | ||
| Pubmed | Calcium dynamics change in degenerating cone photoreceptors. | 2.24e-05 | 2 | 165 | 2 | 27402880 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27270916 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20042668 | ||
| Pubmed | Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury. | 2.24e-05 | 2 | 165 | 2 | 35151662 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37944753 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23548264 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27609772 | ||
| Pubmed | Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer. | 2.24e-05 | 2 | 165 | 2 | 21091771 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 11328816 | ||
| Pubmed | Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. | 2.24e-05 | 2 | 165 | 2 | 19345744 | |
| Pubmed | Lactosylceramide contributes to mitochondrial dysfunction in diabetes. | 2.24e-05 | 2 | 165 | 2 | 26900161 | |
| Interaction | SH3GL3 interactions | 2.77e-07 | 145 | 162 | 10 | int:SH3GL3 | |
| Interaction | LYN interactions | PIK3AP1 FNBP1 SDK2 DSG1 DSP RPS3A SPTAN1 SHISA2 NEDD9 SLC6A8 MET CSF2RB SLC12A4 CASKIN2 PIK3CG SCARB1 SMARCA1 PLD1 SLC12A7 | 5.55e-06 | 720 | 162 | 19 | int:LYN |
| Interaction | H2BC9 interactions | EPRS1 FRAS1 DNAH10 DSG1 DSP NOA1 SPTAN1 NEB HNRNPD ADCY7 MDC1 KIF5A MAPK7 MVP | 1.55e-05 | 446 | 162 | 14 | int:H2BC9 |
| Interaction | AAR2 interactions | EPRS1 INTU ACACA DSP RPS3A PARK7 HSPH1 PRSS56 PAICS HNRNPD TXNDC12 TUBB4B SLC16A3 HPRT1 KDR GCN1 G6PD | 2.29e-05 | 657 | 162 | 17 | int:AAR2 |
| Interaction | ACE2 interactions | EPRS1 ACACA DSG1 DSP RPS3A PARK7 SPTAN1 PFKL PAICS HNRNPD CHRNA7 NUP205 MYOF TUBB4B BTN3A3 CSF2RB PRRC2C HPRT1 SCARB1 MDC1 GCN1 MVP G6PD | 2.67e-05 | 1106 | 162 | 23 | int:ACE2 |
| GeneFamily | Ferlin family | 6.02e-04 | 6 | 116 | 2 | 828 | |
| GeneFamily | Immunoglobulin like domain containing | 1.54e-03 | 193 | 116 | 6 | 594 | |
| GeneFamily | Chloride voltage-gated channels | 1.78e-03 | 10 | 116 | 2 | 302 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.78e-03 | 10 | 116 | 2 | 53 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | SLC29A3 SDK2 RPS3A ZNF185 ITGAM ARHGAP6 CLCN4 KCNJ5 SCARB1 CD101 PLCB2 LOXL3 KIF5A ARRDC2 PADI2 PCDH1 CRTAP | 4.68e-06 | 740 | 165 | 17 | M41202 |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 5.05e-06 | 199 | 165 | 9 | M7319 | |
| Coexpression | HALLMARK_MTORC1_SIGNALING | 5.26e-06 | 200 | 165 | 9 | M5924 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | FLNC CYP2B6 SDK2 FOSL2 MEX3D L1CAM RHBDL1 ADCY6 SLC6A8 MSRB2 ARHGAP6 MAST4 CLCN4 P2RX2 SCARB1 USP32 B9D1 POGLUT2 | 1.82e-05 | 909 | 165 | 18 | M41018 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RELN MFHAS1 MTHFD2 FOSL2 HSPH1 ADCY7 TXNRD1 SLC6A8 BTN3A3 OSBPL2 CSGALNACT2 CLCN6 UPF2 DCUN1D2 MAPK7 MMP13 SLC12A7 | 1.82e-05 | 822 | 165 | 17 | M6782 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.86e-05 | 179 | 165 | 8 | M39308 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 2.93e-05 | 139 | 165 | 7 | M8948 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | 3.98e-05 | 199 | 165 | 8 | M7711 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN | 4.12e-05 | 200 | 165 | 8 | M4889 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP | 4.12e-05 | 200 | 165 | 8 | M8638 | |
| Coexpression | GSE6875_WT_VS_FOXP3_KO_TREG_UP | 4.12e-05 | 200 | 165 | 8 | M6803 | |
| Coexpression | NFE2L2.V2 | PDE6B MTHFD2 L1CAM SHISA2 STAT4 TXNRD1 CD101 ELAPOR1 LOXL3 G6PD PCK2 CRTAP | 4.48e-05 | 469 | 165 | 12 | M2870 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.59e-08 | 193 | 165 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-08 | 199 | 165 | 9 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 184 | 165 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 184 | 165 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-07 | 184 | 165 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.98e-07 | 131 | 165 | 7 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.15e-07 | 192 | 165 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.63e-06 | 178 | 165 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 5.96e-06 | 185 | 165 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.96e-06 | 185 | 165 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.96e-06 | 185 | 165 | 7 | 25781cf68e693e97dc1885e2879ab24fa946b51e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.96e-06 | 185 | 165 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 165 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 7.10e-06 | 190 | 165 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.34e-06 | 191 | 165 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.34e-06 | 191 | 165 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 7.60e-06 | 192 | 165 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 7.60e-06 | 192 | 165 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.60e-06 | 192 | 165 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.60e-06 | 192 | 165 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.13e-06 | 194 | 165 | 7 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.13e-06 | 194 | 165 | 7 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-06 | 196 | 165 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.69e-06 | 196 | 165 | 7 | 07b557b8530c19ca5b31ad2eac00c36ef1939266 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.98e-06 | 197 | 165 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 197 | 165 | 7 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.98e-06 | 197 | 165 | 7 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.28e-06 | 198 | 165 | 7 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.28e-06 | 198 | 165 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.28e-06 | 198 | 165 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 165 | 7 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-05 | 149 | 165 | 6 | a464c0fd54e3c9e1d40d95b49489cb9371dd7c24 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 156 | 165 | 6 | a09e3aefe78d63ad5428ad48c6f83e547eb819f6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 156 | 165 | 6 | 39aa3adbee9f04cdc0055487d393edfa515e062b | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 157 | 165 | 6 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 157 | 165 | 6 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | Club_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-05 | 164 | 165 | 6 | 4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.39e-05 | 164 | 165 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 166 | 165 | 6 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 4.15e-05 | 170 | 165 | 6 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-05 | 171 | 165 | 6 | fd59ac4a39748840b2ee1c930ea475433ff61485 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-05 | 171 | 165 | 6 | 4347e6f62c04ea43299893ad4b79719049009a56 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-05 | 171 | 165 | 6 | d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.28e-05 | 171 | 165 | 6 | d382430e5cdd0f2aac4fc093d8fe8d66efb4629b | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 172 | 165 | 6 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-05 | 173 | 165 | 6 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-05 | 173 | 165 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | f2eb0199f59e1e2f46da344c05289876bd254fa3 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | 9019011eb8d9b7a95804fc11434f0fd42418103a | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.72e-05 | 174 | 165 | 6 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 174 | 165 | 6 | deafbd0c2523afe09cc42f8c7b33945f3f5c00b4 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.03e-05 | 176 | 165 | 6 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.19e-05 | 177 | 165 | 6 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.36e-05 | 178 | 165 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.52e-05 | 179 | 165 | 6 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 179 | 165 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 5.88e-05 | 181 | 165 | 6 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.06e-05 | 182 | 165 | 6 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | 0f06309318c064f0ebdb12a46226b90032290137 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-05 | 182 | 165 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.24e-05 | 183 | 165 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 183 | 165 | 6 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-05 | 185 | 165 | 6 | 19fa853f6f746ccf232a343b3c9c7a5e55800409 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 185 | 165 | 6 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 185 | 165 | 6 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.78e-05 | 59 | 165 | 4 | e6cbbe1a4961066cae8f8c03a838f37e60a5391a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.78e-05 | 59 | 165 | 4 | dbb61f03be7d2c7fa7d32c743fcff2dc91ae0d75 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.04e-05 | 187 | 165 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-05 | 188 | 165 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 7.25e-05 | 188 | 165 | 6 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 189 | 165 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 7.68e-05 | 190 | 165 | 6 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 190 | 165 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 190 | 165 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 7.68e-05 | 190 | 165 | 6 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 190 | 165 | 6 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 190 | 165 | 6 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-C1ql3_(Nucleus_of_the_lateral_olfactory_tract_(LOT))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 61 | 165 | 4 | a9f5cbbe5683f2574130ffe8d375d693b9aa8f2d | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-C1ql3_(Nucleus_of_the_lateral_olfactory_tract_(LOT))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.73e-05 | 61 | 165 | 4 | 3797e1e122818211664847bb54730034af61430e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.91e-05 | 191 | 165 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 191 | 165 | 6 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-05 | 191 | 165 | 6 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-05 | 191 | 165 | 6 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 191 | 165 | 6 | d2311a5b0cf186839000f9f272b6fbc2270ddb44 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-05 | 191 | 165 | 6 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 191 | 165 | 6 | 6676ef9aeb890668cb69e67865404061b8467c25 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-05 | 191 | 165 | 6 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.91e-05 | 191 | 165 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.91e-05 | 191 | 165 | 6 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 191 | 165 | 6 | a157cee0fbc9dce64308128c3578e7327fa178b7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 192 | 165 | 6 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 8.14e-05 | 192 | 165 | 6 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| Drug | ethanol | CACNA1F CYP2B6 SLC29A3 SPTAN1 L1CAM PFKL ITGAM ADCY6 ADCY7 CHRNA7 SLC6A3 CSF2RB PIK3CG MTR KDR PLCB2 PLD1 MAPK7 G6PD ACSS3 CA7 | 6.15e-07 | 837 | 163 | 21 | CID000000702 |
| Drug | serotonin | FOSL2 PFKL ITGB3 ADCY6 ADCY7 CHRNA7 BUD23 SLC6A3 CLCN4 CLCN6 P2RX2 KCNJ5 PLCB2 LOXL3 PLD1 MAPK7 | 2.50e-06 | 554 | 163 | 16 | CID000005202 |
| Drug | H2O2 | EPRS1 CRISP2 PARK7 CYP51A1 ITGAM ADCY6 ADCY7 SLC6A3 MSRB2 MET CLCN4 SLC12A4 CLCN6 CLPB PIK3CG HPRT1 SCARB1 KDR PLCB2 LOXL3 PLD1 MAPK7 G6PD CDH11 | 3.89e-06 | 1183 | 163 | 24 | CID000000784 |
| Drug | noradrealine | CACNA1F CACNA1S ACACA HSPH1 ADCY6 ADCY7 SLC6A3 SLC16A3 P2RX2 PIK3CG PLCB2 LOXL3 PLD1 MAPK7 BSN MMP13 | 4.02e-06 | 575 | 163 | 16 | CID000000951 |
| Drug | furosemide | PAICS ADCY6 ADCY7 NLRP6 SLC6A3 CLCN4 SLC12A4 CLCN6 MTR SLC12A7 CA7 | 4.46e-06 | 272 | 163 | 11 | CID000003440 |
| Drug | meperidine | 5.95e-06 | 63 | 163 | 6 | CID000004058 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; HL60; HG-U133A | 6.50e-06 | 181 | 163 | 9 | 1786_DN | |
| Drug | amifostine | 7.15e-06 | 65 | 163 | 6 | CID000002141 | |
| Drug | quinoline | 9.31e-06 | 68 | 163 | 6 | ctd:C037219 | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.62e-06 | 190 | 163 | 9 | 5674_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.34e-05 | 198 | 163 | 9 | 2057_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.34e-05 | 198 | 163 | 9 | 4333_UP | |
| Drug | MK-886; Up 200; 1uM; MCF7; HG-U133A | 1.34e-05 | 198 | 163 | 9 | 264_UP | |
| Drug | 6-OHDA | 1.60e-05 | 255 | 163 | 10 | CID000004624 | |
| Drug | glutamate | CACNA1F EPRS1 CACNA1S RELN TNC PFKL PAICS ADCY6 ADCY7 CHRNA7 SLC6A3 CLCN4 CLCN6 P2RX2 MTR PLCB2 PLD1 BSN G6PD PCK2 | 1.90e-05 | 962 | 163 | 20 | CID000000611 |
| Drug | manganese-ATP | 2.85e-05 | 25 | 163 | 4 | CID000124341 | |
| Drug | Curcumin | RELN ACACA TNC FOSL2 ITGAM ITGB3 HNRNPD STAT4 TXNRD1 CSF2RB CLCN6 HPRT1 SCARB1 AATF KDR MMP13 G6PD CDH11 | 4.02e-05 | 850 | 163 | 18 | ctd:D003474 |
| Drug | papaverine | 4.08e-05 | 176 | 163 | 8 | CID000004680 | |
| Drug | INT-formazan | 5.09e-05 | 2 | 163 | 2 | CID000111334 | |
| Drug | spiromesifen | 5.09e-05 | 2 | 163 | 2 | CID009907412 | |
| Drug | ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid | 5.09e-05 | 2 | 163 | 2 | ctd:C095651 | |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | FNBP1 L1CAM SHISA2 SALL4 PFKL PAICS NEDD9 TUBB4B MAST4 OSBPL2 SLC12A4 PRRC2C HPRT1 SCARB1 MDC1 NUP210 KDR MVP PCK2 | 6.11e-05 | 961 | 163 | 19 | ctd:C029497 |
| Drug | magnesium | CACNA1S DPYSL2 DNAH10 TNC MTHFD2 PFKL ITGAM ITGB3 PAICS ADCY6 ADCY7 TUBB4B CLPB KCNJ5 HPRT1 MTR AATF PLCB2 PLD1 MMP13 G6PD PCK2 ALPG | 7.32e-05 | 1325 | 163 | 23 | CID000000888 |
| Drug | butein; Up 200; 10uM; MCF7; HG-U133A | 8.10e-05 | 194 | 163 | 8 | 607_UP | |
| Drug | muscarine | 8.19e-05 | 144 | 163 | 7 | CID000009308 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | FLNC TNC FKBP9 TXNRD1 MYOF SLC12A4 CASKIN2 KIF5A SLC12A7 PCK2 CRTAP | 8.20e-05 | 373 | 163 | 11 | ctd:C540355 |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 2056_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; HL60; HG-U133A | 8.70e-05 | 196 | 163 | 8 | 2031_DN | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 3907_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4415_UP | |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 2058_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 6676_UP | |
| Drug | prinomastat | 8.81e-05 | 33 | 163 | 4 | CID000466151 | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HG-U133A | 9.01e-05 | 197 | 163 | 8 | 1944_DN | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 2177_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 4974_DN | |
| Drug | L-adrenaline | CACNA1S ACACA ITGB3 ADCY6 ADCY7 CLCN4 CLCN6 PLCB2 LOXL3 MAPK7 G6PD PCK2 | 9.30e-05 | 446 | 163 | 12 | CID000000838 |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 3523_UP | |
| Drug | aspartate | MTHFD2 FKBP9 PFKL PAICS CLCN4 SLC12A4 CLCN6 KCNJ5 FKBP7 SLC12A7 G6PD PCK2 CRTAP | 9.54e-05 | 518 | 163 | 13 | CID000000424 |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 7125_UP | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 3198_UP | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 5544_UP | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | 9.67e-05 | 199 | 163 | 8 | 284_DN | |
| Drug | didodecyldimethylammonium bromide | 9.77e-05 | 13 | 163 | 3 | CID000018669 | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 163 | 8 | 3167_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 163 | 8 | 3840_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; HL60; HT_HG-U133A | 1.00e-04 | 200 | 163 | 8 | 2434_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 163 | 8 | 3833_UP | |
| Drug | AC1Q4Y39 | 1.03e-04 | 65 | 163 | 5 | CID000004402 | |
| Drug | endrine | 1.16e-04 | 106 | 163 | 6 | CID000003048 | |
| Disease | Severe dermatitis, multiple allergies, metabolic wasting syndrome | 2.96e-05 | 2 | 161 | 2 | C3809719 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 3.38e-05 | 12 | 161 | 3 | C1861063 | |
| Disease | high grade glioma (biomarker_via_orthology) | 6.91e-05 | 15 | 161 | 3 | DOID:3070 (biomarker_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 8.13e-05 | 42 | 161 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | Striate palmoplantar keratoderma | 8.84e-05 | 3 | 161 | 2 | C4707237 | |
| Disease | bipolar disorder (is_marker_for) | 1.45e-04 | 19 | 161 | 3 | DOID:3312 (is_marker_for) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.76e-04 | 4 | 161 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Gilles de la Tourette syndrome (implicated_via_orthology) | 1.76e-04 | 4 | 161 | 2 | DOID:11119 (implicated_via_orthology) | |
| Disease | sarcoma (is_marker_for) | 2.93e-04 | 5 | 161 | 2 | DOID:1115 (is_marker_for) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.22e-04 | 108 | 161 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | nicotine dependence (is_implicated_in) | 4.37e-04 | 6 | 161 | 2 | DOID:0050742 (is_implicated_in) | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 4.37e-04 | 6 | 161 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Epilepsy, Generalized | 4.37e-04 | 6 | 161 | 2 | C0014548 | |
| Disease | Mental Depression | 5.11e-04 | 254 | 161 | 7 | C0011570 | |
| Disease | Autistic Disorder | 6.00e-04 | 261 | 161 | 7 | C0004352 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 6.10e-04 | 7 | 161 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 7.01e-04 | 268 | 161 | 7 | C0001973 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | Meckel syndrome (implicated_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 1.02e-03 | 81 | 161 | 4 | C3711374 | |
| Disease | Depressive disorder | 1.09e-03 | 289 | 161 | 7 | C0011581 | |
| Disease | Schizophrenia | CACNA1F RELN CSMD2 ITGAM ITGB3 ADCY7 CHRNA5 CHRNA7 SLC6A3 MET CSF2RB MTR KDR | 1.16e-03 | 883 | 161 | 13 | C0036341 |
| Disease | obesity (implicated_via_orthology) | 1.20e-03 | 215 | 161 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 1.29e-03 | 10 | 161 | 2 | cv:C0265215 | |
| Disease | Microphthalmos | 1.58e-03 | 11 | 161 | 2 | C0026010 | |
| Disease | pars orbitalis volume measurement | 1.58e-03 | 11 | 161 | 2 | EFO_0010320 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.88e-03 | 12 | 161 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.88e-03 | 12 | 161 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.88e-03 | 12 | 161 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.88e-03 | 12 | 161 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.88e-03 | 12 | 161 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.88e-03 | 12 | 161 | 2 | C1848172 | |
| Disease | Congenital myopathy (disorder) | 1.88e-03 | 12 | 161 | 2 | C0270960 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.91e-03 | 45 | 161 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.22e-03 | 13 | 161 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.22e-03 | 13 | 161 | 2 | C4041558 | |
| Disease | Sjogren's Syndrome | 2.22e-03 | 13 | 161 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 2.22e-03 | 13 | 161 | 2 | C0086981 | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.23e-03 | 100 | 161 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | RAP1GAP NOA1 SPTAN1 TP53I3 ETV4 OLA1 STAT4 SLC6A3 KMT2D CDH20 SLC16A3 ELAPOR1 MTR KDR | 2.34e-03 | 1074 | 161 | 14 | C0006142 |
| Disease | brain ischemia (biomarker_via_orthology) | 2.40e-03 | 102 | 161 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.40e-03 | 169 | 161 | 5 | DOID:3908 (is_marker_for) | |
| Disease | ulcerative colitis | 2.51e-03 | 335 | 161 | 7 | EFO_0000729 | |
| Disease | Tobacco Dependence | 2.58e-03 | 14 | 161 | 2 | C0040332 | |
| Disease | Spastic Paraplegia, Hereditary | 2.58e-03 | 14 | 161 | 2 | C0037773 | |
| Disease | Nicotine Dependence | 2.58e-03 | 14 | 161 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 2.58e-03 | 14 | 161 | 2 | C0376384 | |
| Disease | Meckel-Gruber syndrome | 2.97e-03 | 15 | 161 | 2 | C0265215 | |
| Disease | ovarian carcinoma (is_implicated_in) | 2.97e-03 | 15 | 161 | 2 | DOID:4001 (is_implicated_in) | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.97e-03 | 15 | 161 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.97e-03 | 15 | 161 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.97e-03 | 15 | 161 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.97e-03 | 15 | 161 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.97e-03 | 15 | 161 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.97e-03 | 15 | 161 | 2 | C0079758 | |
| Disease | inflammatory bowel disease | 3.36e-03 | 449 | 161 | 8 | EFO_0003767 | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.40e-03 | 55 | 161 | 3 | C0079744 | |
| Disease | Night blindness, congenital stationary | 3.81e-03 | 17 | 161 | 2 | C0339535 | |
| Disease | Polydactyly | 3.93e-03 | 117 | 161 | 4 | C0152427 | |
| Disease | Libman-Sacks Disease | 3.95e-03 | 58 | 161 | 3 | C0242380 | |
| Disease | aspartate aminotransferase measurement | PIK3AP1 CACNA1S MFHAS1 FOSL2 DNAH2 CILP2 CDH20 CLCN4 SCARB1 FKBP7 IGSF21 GCN1 | 4.12e-03 | 904 | 161 | 12 | EFO_0004736 |
| Disease | Child Behaviour Checklist assessment | 4.27e-03 | 18 | 161 | 2 | EFO_0005661 | |
| Disease | Meckel syndrome type 1 | 4.27e-03 | 18 | 161 | 2 | C3714506 | |
| Disease | Bipolar Disorder | 4.82e-03 | 477 | 161 | 8 | C0005586 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.98e-03 | 63 | 161 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | sucrose liking measurement | 5.27e-03 | 20 | 161 | 2 | EFO_0010157 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 5.27e-03 | 20 | 161 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | Lymphoma, Follicular | 5.27e-03 | 20 | 161 | 2 | C0024301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGPPELFYDETEARK | 11 | O43709 | |
| GYPVVPAEKRSSGER | 181 | Q92667 | |
| KYGDVFTVHLGPRPV | 61 | P20813 | |
| EPPRKVGIFLDYETG | 456 | O00478 | |
| EPAVPSNGVKTGERY | 1911 | Q7Z408 | |
| FSVPVGEIKPQGVYD | 201 | Q14511 | |
| FDIYREVGGEPVPVT | 141 | Q8WTX7 | |
| PVVAGVIGARKPQYD | 1091 | O43306 | |
| GDVLQPAKPEYRVGE | 41 | P0C7U1 | |
| PGKTPVYAEVKRVGD | 521 | Q9UL18 | |
| FKSPEYPEGRDIIVI | 1666 | Q13085 | |
| VDDIPDRPAGVGVYT | 426 | P51793 | |
| IFGPDGSRIPYIEQV | 36 | A6NC42 | |
| PVIAGVIGARKPQYD | 996 | P51828 | |
| ELIFGEPVIFKGRPY | 791 | Q9NVE4 | |
| PAKVEFGVYESGPRK | 686 | Q6ZUJ8 | |
| FGVYESGPRKSVIPP | 691 | Q6ZUJ8 | |
| DEILDFVYGVGPKSP | 116 | P16562 | |
| DRKGYTPGEVIPVFA | 191 | Q8TBH0 | |
| VSEYPGVKTVRFPDG | 91 | P36544 | |
| KEGILFVTYPDGRPT | 356 | Q6NXG1 | |
| IKQEGVGAFREGPPY | 321 | P43268 | |
| EEISPTKFPGLYRTG | 31 | Q15311 | |
| YVKEVAKPSPGEGEV | 16 | Q53FA7 | |
| GEATKGYLDDPTVPR | 316 | P11413 | |
| VDKYDPGALVIPFSG | 251 | Q9NTK5 | |
| QGEEIIAYKPPGFSL | 791 | Q92621 | |
| PGKEEISYIFEGDPI | 361 | Q9HCL0 | |
| GYGFRVITEKCPEGI | 151 | P48544 | |
| FPVLVIYKDSERPSG | 61 | A0A075B6K0 | |
| GGPAPDVVSDKIYQI | 141 | Q15124 | |
| EAFPKGYDIEGPEKV | 56 | Q5VTT2 | |
| VTVAFVVDRRGPGPY | 1781 | Q8TEM1 | |
| KGSFLVYPDGDVSRP | 1041 | O60840 | |
| AIKDILRPTVPYGEF | 116 | Q13164 | |
| LAGFPRKPYEGRVEI | 46 | P58215 | |
| VDYVPSSRKVEFGPG | 2846 | Q86XX4 | |
| SRKAGFFLPPDEYVV | 1956 | Q14676 | |
| RGYGKVQAEFPLGPV | 166 | O76036 | |
| GKVPVVVSYRPARGV | 921 | Q9Y4C4 | |
| PVFVVSYAKDLGVPD | 246 | O15427 | |
| VTEGSGRYIPRKPFP | 461 | Q16555 | |
| GDVLQPAKPEYRVGE | 656 | Q9NR71 | |
| AVIIPPEVTGYKAGV | 741 | Q6UXG2 | |
| PNGKADPYVVVSAGR | 1266 | A9Z1Z3 | |
| GVPYPEAKIGRFVVQ | 451 | Q92598 | |
| SSGYEQGKVPEVPRA | 3186 | Q9UPA5 | |
| DDFVEYARPVVTGGK | 241 | Q6PH85 | |
| GKEPQPGETVIYVAG | 206 | Q99447 | |
| FGGRRPKGVPLVYEA | 451 | Q16822 | |
| YPRLIEEDFPGIGDK | 416 | P45452 | |
| YTFQLKAVDGGVPPR | 681 | Q08174 | |
| KAVDGGVPPRSAYVG | 686 | Q08174 | |
| AKKEGPYDVVVLPGG | 61 | Q99497 | |
| APTPFDRNYGTKLGV | 666 | P17858 | |
| SGPRTPDGREIVFYK | 301 | P35913 | |
| GPKTPDGREVNFYKI | 306 | P51160 | |
| EPIVKFPGAVDGATY | 76 | Q96S96 | |
| GSHPERVKVYGPGVE | 761 | Q14315 | |
| YIVTPGRDKEPVFAV | 306 | Q86XN8 | |
| SEAPGKCVPYAVIEG | 56 | Q969V5 | |
| TFRVTAINKYGPGEP | 686 | P32004 | |
| DAGEVTEAGKAYVPP | 626 | Q92616 | |
| PGSRKAVDGVVAVFY | 261 | Q8NGN5 | |
| PVKELLGPDFGYVTR | 381 | Q9Y2J8 | |
| YVPGVAFGDIDKLRP | 411 | O94880 | |
| TDRIGYFPPGIVEVV | 331 | Q8WXE0 | |
| YFPPGIVEVVSKRVG | 336 | Q8WXE0 | |
| EGPVFRPGSKTYVVT | 381 | Q02413 | |
| EGPGTYIPRKEVEVV | 146 | Q14764 | |
| GQYIRLVEPGSPAEK | 36 | O14745 | |
| YGFVVEKTAAARLPP | 256 | Q96EY5 | |
| KNVPPFGLDGVYISE | 1396 | P78509 | |
| KRTPRSVGYKPDFVG | 166 | P00492 | |
| VFPEPEGRYFLLVVG | 581 | Q9ULD6 | |
| EDAAPGGSEKLYRVP | 686 | O43182 | |
| PGYVLKDGARPDVTE | 416 | P10696 | |
| EEYVKPPEGGSVFSI | 96 | Q9UBL9 | |
| GEKRIITIPPFLAYG | 216 | O95302 | |
| NPDDYGGIKVIRVPS | 111 | P30532 | |
| GAKLPSEYGVIPFES | 136 | Q8N6G5 | |
| EPVAAGSGIPEVKCY | 151 | P51797 | |
| GEKRKVVIPPSFAYG | 106 | Q9Y680 | |
| VYFKRDGEPIDAVPL | 181 | Q96ID5 | |
| SGFEGYVELPPIEGR | 761 | P32927 | |
| VQKGPLFRAEGYPVS | 26 | Q93033 | |
| VERYSRKVFVGGLPP | 436 | Q8NE35 | |
| QLVIEAYKSGFEPPG | 266 | Q96RU3 | |
| PPIGDDEVTVGKFYA | 1511 | Q13698 | |
| PGFYFVEVPEDVAIG | 391 | Q9HBT6 | |
| LTPVIGGYPVEKFVA | 281 | O75718 | |
| PVEEAYKRGLVGIEF | 2311 | P15924 | |
| GKGVAYDVPNPVFLE | 146 | Q16850 | |
| FVIEEYTGPDPVLVG | 61 | P55287 | |
| IKPISIAGGFYGEEP | 246 | P15408 | |
| APEVILRQGYGKPVD | 751 | O15021 | |
| GPAIPVVYDFGDAKK | 216 | Q8WWU7 | |
| LAPPYVKGVDESGDV | 2311 | Q8TEP8 | |
| GVLYEGKERPKPGFQ | 106 | O75064 | |
| RIGFGAFVDKPVSPY | 176 | P05106 | |
| VIGGKPYVFDRVFPP | 41 | Q12840 | |
| TEEKAKVGPGDRPLY | 146 | Q7Z7F0 | |
| VTGGPLEGPYRLKQF | 81 | P43166 | |
| ERHEVAKFIGSPPGY | 416 | Q9H078 | |
| RPEYTDPKVVAQGEG | 141 | Q9UPM9 | |
| PGYAGRTELPESVKA | 1936 | Q8IVF4 | |
| GEIKSYGRPPAQVEI | 3111 | Q9P225 | |
| IYAGVIKSAFDPPDI | 291 | Q9Y666 | |
| SGDPGKGPITRYVIE | 1846 | Q58EX2 | |
| RAPPTYVKVEVPGTF | 831 | Q9UJQ4 | |
| YVKVEVPGTFVGPST | 836 | Q9UJQ4 | |
| YQVPKEDVDRKPVGG | 466 | Q9C0B2 | |
| FYGPEPALEVARKTL | 71 | P59044 | |
| QDAGVPGYLPREKFL | 151 | Q8NC60 | |
| PGKPGVYTRVAVFKD | 316 | P0CW18 | |
| IDIFTPGKPGEYDLE | 441 | Q9HAU5 | |
| PDTPEEKIREYFGGF | 191 | Q14103 | |
| EDGPLPKYGRLVDAV | 216 | P0C091 | |
| YKVFPNSAPLEGGTR | 566 | P08581 | |
| GGALEYVPKAVSQPR | 196 | Q8N1G1 | |
| YGPKIVPRELAEATG | 436 | Q9BZD2 | |
| GKVTVRFPPEASGYL | 196 | P07814 | |
| GGPFKAPTIETVVLY | 146 | Q9BYC8 | |
| FEVSPSYVKGGPLRD | 171 | P28370 | |
| YEAGTKPRDSGVVPV | 6 | Q8IUX1 | |
| IYKEVIAVQGPPDGT | 881 | O43426 | |
| EGVRQKAGYITPVPG | 296 | P13995 | |
| RVYVVIPLLPGFEGD | 816 | Q13393 | |
| IEGPPSFRGQSVKYV | 121 | Q92546 | |
| IVGKPVGETPDYINF | 331 | Q8NE09 | |
| TGAKVERADGYEPPV | 246 | P61247 | |
| IRAGVPKINFSGPDY | 401 | Q8NA58 | |
| KYAPRPIFISGTIVD | 216 | Q99707 | |
| GFIRSSEGPKPEKVY | 971 | Q9Y520 | |
| GPDGPLYKVSVTARD | 326 | P47736 | |
| RADKDGPDGSAVPIY | 101 | Q6UWI4 | |
| GVFEGIPTYRFVAPK | 291 | Q8WTV0 | |
| YIPKGTRFGPLIGEI | 106 | O75626 | |
| KVAESGPGLAFIAYP | 376 | P48029 | |
| NIKGADVGVYIPDPT | 1101 | Q9UHV7 | |
| KFGDPLGYEDVIPEA | 261 | P11215 | |
| GPLDEPGLGVYKRFV | 156 | O75783 | |
| ERTGKPFNPLLGETY | 146 | Q9H1P3 | |
| IYAGGIKSIFDPPVF | 291 | Q9UP95 | |
| PDTRYLVDGTKPNAG | 301 | Q9NY61 | |
| EGKPVGTPDAGAYFR | 366 | Q9H6R3 | |
| GKPYSGPVEARVTFV | 596 | Q8IUL8 | |
| ESFRVPYDPGLKAGA | 781 | P48736 | |
| RVFFVYVGGESPLKE | 151 | Q96JJ7 | |
| RIKAEYEGDGIPTVF | 311 | P22234 | |
| TGERPRYLGIPGDKE | 311 | Q16881 | |
| ITVKPDFTGLKGPYR | 236 | Q9NXB0 | |
| TREKGTEPPFSGIYL | 66 | Q9Y3D2 | |
| EVSRPTERGDKGYVP | 681 | Q14765 | |
| TERGDKGYVPSVFIP | 686 | Q14765 | |
| KPYVDGKGRELPTAF | 2446 | Q13813 | |
| GGKYVPRAVLVDLEP | 56 | P68371 | |
| DVAKDGPGLIFIIYP | 381 | Q01959 | |
| VGKPYRGVKPVFSIG | 541 | Q9NUY8 | |
| ARVATYLPAPEGLKF | 706 | P24821 | |
| TYVEVELFGLPGDPK | 701 | Q00722 | |
| GPGLKADVVLPARYF | 36 | Q6UW63 | |
| GSEDPLKRPVVYVKG | 171 | Q9ULT6 | |
| LGASPYPGVKIDEEF | 1101 | P35968 | |
| KDEDFSPDGGYIPRI | 101 | O95881 | |
| APTGYIIRGVFTKPI | 81 | O15231 | |
| VLGDGVPPKVAEVIY | 51 | Q8NFA0 | |
| VPPKVAEVIYCSFGG | 56 | Q8NFA0 | |
| LRTIGVGKYEFTDPG | 296 | Q96CT2 | |
| VFPDTKPYGALGLEV | 4751 | O14686 | |
| VVGEFKGSFRIYPLP | 1516 | Q9NZM1 | |
| GYTLGPKDVPFVHVR | 4996 | P20929 |